{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:23:00Z","timestamp":1788841380485,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR300545"],"award-info":[{"award-number":["NIHR300545"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.rpth.2023.102162","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T22:31:22Z","timestamp":1691533882000},"page":"102162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Thromboembolism in nephrotic syndrome: controversies and uncertainties"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9908-5160","authenticated-orcid":false,"given":"Kathrine","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Ragy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jecko","family":"Thachil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durga","family":"Kanigicherla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2023.102162_bib1","series-title":"On renal and urinary affections","author":"Dickinson","year":"1885"},{"key":"10.1016\/j.rpth.2023.102162_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.thromres.2012.04.015","article-title":"Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome-a prospective study","volume":"130","author":"Li","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.102162_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2369-13-107","article-title":"Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study","volume":"13","author":"Kumar","year":"2012","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.rpth.2023.102162_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ki.2011.312","article-title":"Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis","volume":"81","author":"Barbour","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2023.102162_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2215\/CJN.04250511","article-title":"Venous thromboembolism in patients with membranous nephropathy","volume":"7","author":"Lionaki","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2023.102162_bib6","first-page":"555","article-title":"Histological diagnosis and risk of renal vein thrombosis, and other thrombotic complications in primitive nephrotic syndrome","volume":"54","author":"H\u00e2rza","year":"2013","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.rpth.2023.102162_bib7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1148\/radiol.14140121","article-title":"Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT","volume":"273","author":"Zhang","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.rpth.2023.102162_bib8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10157-015-1149-4","article-title":"Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome","volume":"20","author":"Li","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.rpth.2023.102162_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.ajkd.2016.10.032","article-title":"The clinical course of minimal change nephrotic syndrome with onset in adulthood or late adolescence: a case series","volume":"69","author":"Maas","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.rpth.2023.102162_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/ndt\/gfw227","article-title":"Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome","volume":"32","author":"Gyamlani","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rpth.2023.102162_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12882-018-0999-x","article-title":"Adult minimal-change disease: observational data from a UK centre on patient characteristics, therapies, and outcomes","volume":"19","author":"Fenton","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.rpth.2023.102162_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.24920\/11809","article-title":"A\u00a0cohort study of incidences and risk factors for thromboembolic events in patients with idiopathic membranous nephropathy","volume":"33","author":"Zou","year":"2018","journal-title":"Chin Med Sci J"},{"key":"10.1016\/j.rpth.2023.102162_bib13","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/ndt\/gfaa134","article-title":"Risk factors for venous thromboembolism in patients with nephrotic syndrome: a\u00a0retrospective cohort study","volume":"36","author":"Shinkawa","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rpth.2023.102162_bib14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.amjmed.2021.11.018","article-title":"Risk of arterial thromboembolism, venous thromboembolism, and bleeding in patients with nephrotic syndrome: a population-based cohort study","volume":"135","author":"Vestergaard","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2023.102162_bib15","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2006111300","article-title":"Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum","volume":"18","author":"Glassock","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2023.102162_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2005.03.030","article-title":"Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management","volume":"118","author":"Singhal","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.102162_bib17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0002-9343(80)80006-4","article-title":"The clinical spectrum of renal vein thrombosis: acute and chronic","volume":"69","author":"Llach","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2023.102162_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archinte.1977.03630150039012","article-title":"On the incidence of renal vein thrombosis in the nephrotic syndrome","volume":"137","author":"Llach","year":"1977","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rpth.2023.102162_bib19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ki.1983.28","article-title":"Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance","volume":"23","author":"Wagoner","year":"1983","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2023.102162_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000167654","article-title":"Idiopathic nephrotic syndrome of the adult with asymptomatic thrombosis of the renal vein","volume":"8","author":"Velasquez Forero","year":"1988","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.rpth.2023.102162_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2215\/CJN.05250419","article-title":"Prophylactic anticoagulation in adult patients with nephrotic syndrome","volume":"15","author":"Gordon-Cappitelli","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2023.102162_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000187205","article-title":"Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted?","volume":"63","author":"Bellomo","year":"1993","journal-title":"Nephron"},{"key":"10.1016\/j.rpth.2023.102162_bib23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/pgmj.57.671.566","article-title":"Renal vein thrombosis in nephrotic syndrome--a prospective study and review","volume":"57","author":"Chugh","year":"1981","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.rpth.2023.102162_bib24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","article-title":"High absolute risks and predictors of venous and arterial thromboembolic events in patients with Nephrotic syndrome","volume":"117","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2023.102162_bib25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.1993.292","article-title":"The increased risk of coronary heart disease associated with nephrotic syndrome","volume":"44","author":"Ordo\u00f1ez","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2023.102162_bib26","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(79)92067-1","article-title":"Does the nephrotic syndrome increase the risk of cardiovascular disease?","volume":"2","author":"Wass","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2023.102162_bib27","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.kint.2015.12.041","article-title":"Patients with primary membranous nephropathy are at high risk of cardiovascular events","volume":"89","author":"Lee","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2023.102162_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/916760","article-title":"Primary nephrotic syndrome in adults as a risk factor for pulmonary embolism: an up-to-date review of the literature","volume":"2014","author":"Mirrakhimov","year":"2014","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.rpth.2023.102162_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/2229-5151.183019","article-title":"Nephrotic syndrome-induced thromboembolism in adults","volume":"6","author":"Al-Azzawi","year":"2016","journal-title":"Int J Crit Illn Inj Sci"},{"key":"10.1016\/j.rpth.2023.102162_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000188355","article-title":"Prevention of thrombotic complications of the nephrotic syndrome by the low-molecular-weight heparin enoxaparin","volume":"69","author":"Rostoker","year":"1995","journal-title":"Nephron"},{"key":"10.1016\/j.rpth.2023.102162_bib31","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/BF01476873","article-title":"Hypercoagulability in the nephrotic syndrome","volume":"58","author":"Andrassy","year":"1980","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.rpth.2023.102162_bib32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-9343(78)90848-3","article-title":"Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome","volume":"65","author":"Kauffmann","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2023.102162_bib33","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/pgmj.70.830.905","article-title":"Arterial thrombosis in the nephrotic syndrome","volume":"70","author":"Fahal","year":"1994","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.rpth.2023.102162_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2141.1982.tb03862.x","article-title":"Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome","volume":"52","author":"Jackson","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2023.102162_bib35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJM197402212900805","article-title":"Platelet function in hyperlipoproteinemia","volume":"290","author":"Carvalho","year":"1974","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2023.102162_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2215\/CJN.10131011","article-title":"Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease","volume":"7","author":"Kerlin","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2023.102162_bib37","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2023.102162_bib38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ekir.2019.12.001","article-title":"A\u00a0systematic review of prophylactic anticoagulation in nephrotic syndrome","volume":"5","author":"Lin","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.rpth.2023.102162_bib39","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.ekir.2022.01.499","article-title":"POS-469 a retrospective analysis of venous thromboembolism incidence amongst patients with membranous nephropathy: a single centre experience. Is anti-PLA2R an accessory or an accomplice?","volume":"7","author":"Jeyalan","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.rpth.2023.102162_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2165\/00002512-199405010-00003","article-title":"Physiological changes due to age. Implications for the prevention and treatment of thrombosis in older patients","volume":"5","author":"Nurmohamed","year":"1994","journal-title":"Drugs Aging"},{"key":"10.1016\/j.rpth.2023.102162_bib41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11239-010-0442-z","article-title":"Relationship between proteinuria and venous thromboembolism","volume":"30","author":"Kato","year":"2010","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.rpth.2023.102162_bib42","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.kint.2019.01.042","article-title":"The bias between different albumin assays may affect clinical decision-making","volume":"95","author":"van de Logt","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2023.102162_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12882-022-03041-w","article-title":"UK prescribing practice of anticoagulants in patients with chronic kidney disease: a nephrology and haematology-based survey","volume":"24","author":"Parker","year":"2023","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.rpth.2023.102162_bib44","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ki.1994.75","article-title":"Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy","volume":"45","author":"Sarasin","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2023.102162_bib45","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ki.2013.476","article-title":"Personalized prophylactic anticoagulation decision analysis in\u00a0patients with membranous nephropathy","volume":"85","author":"Lee","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2023.102162_bib46","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A\u00a0new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (anticoagulation and risk factors in atrial fibrillation) study","volume":"58","author":"Fang","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2023.102162_bib47","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2023.102162_bib48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12882-019-1336-8","article-title":"Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications","volume":"20","author":"Kelddal","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.rpth.2023.102162_bib49","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2215\/CJN.07190713","article-title":"Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome","volume":"9","author":"Medjeral-Thomas","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2023.102162_bib50","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.kint.2016.01.019","article-title":"Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy?","volume":"89","author":"Hofstra","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2023.102162_bib51","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ekir.2018.02.010","article-title":"Direct-acting oral anticoagulants as prophylaxis against thromboembolism in the nephrotic syndrome","volume":"3","author":"Sexton","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.rpth.2023.102162_bib52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12882-022-02929-x","article-title":"Safety and effectiveness of direct oral anticoagulants in patients with nephrotic syndrome: a report of 21 cases","volume":"23","author":"Kelddal","year":"2022","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.rpth.2023.102162_bib53","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1055\/a-1920-6224","article-title":"Apixaban prophylactic anticoagulation in patients with nephrotic syndrome","volume":"6","author":"Van Meerhaeghe","year":"2022","journal-title":"TH Open"},{"key":"10.1016\/j.rpth.2023.102162_bib54","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/10600280221129348","article-title":"Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in patients with nephrotic syndrome: a retrospective cohort study","volume":"57","author":"Tijani","year":"2023","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rpth.2023.102162_bib55","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923002145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923002145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:29:16Z","timestamp":1762864156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037923002145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2475037923002145"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2023.102162","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboembolism in nephrotic syndrome: controversies and uncertainties","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2023.102162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102162"}}